Micell Technologies
801 Capitola Dr
Suite 104
Durham
NC
27713-4384
USA
919-313-2102
[email protected]
http://www.micell.com
Product Categories
Stents Drug Eluting

Related Content

News
Enrollment Completed in DESSOLVE II Study of the MiStent Drug-Eluting Coronary Stent

July 27, 2011 – Micell Technologies Inc. announced that it has completed patient enrollment in its DESSOLVE II CE mark ...

Home July 27, 2011
arrow
News
Micell Reduces Trial Sample Size for MiStent

June 30, 2011 — Micell Technologies Inc. announced that it has completed its review of the scheduled four-month follow ...

Home June 30, 2011
arrow
News
Consistent, Controlled Drug Delivery Reported With Rapidly Absorbable Stent Coating

May 11, 2011 - Micell Technologies announced that positive preclinical data will be presented at the EuroPCR conference ...

Home May 11, 2011
arrow
News
First Patient Enrolled in Dissolving Drug-Polymer Coronary Stent Trial

February 21, 2011 – The first patient has been enrolled the DESSOLVE II study to support CE mark for a coronary stent ...

Home February 21, 2011
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now